Annual Drug Patent Expirations for VESICARE+LS
Vesicare Ls is a drug marketed by Astellas and is included in one NDA. It is available from one supplier.
The generic ingredient in VESICARE LS is solifenacin succinate. One supplier is listed for this compound. Additional details are available on the solifenacin succinate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com